Loading...

Home
ETF
ADAG

ADAG

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ADAG News

FDA Approves Fast Track Status for ADAG's Colorectal Cancer Treatment

Dec 17 2025NASDAQ.COM

Adagene Receives FDA Fast Track Designation for muzastotug in MSS Colorectal Cancer

Dec 16 2025Globenewswire

Adagene Receives FDA Fast Track Designation for muzastotug in MSS Colorectal Cancer

Dec 16 2025Newsfilter

What’s Driving Adagene's Pre-market Surge?

Dec 16 2025NASDAQ.COM

Adagene and Palvella See Gains Following FDA Fast Track Approvals

Dec 16 2025SeekingAlpha

Guggenheim Begins Coverage of Adagene with a Buy Rating and Sets Price Target at $9

Nov 24 2025Benzinga

Adagene Reports First Patient Treated in Randomized Dose Optimization Group of Phase 2 Trial for Muzastotug (ADG126) Combined with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Oct 31 2025Newsfilter

LUCID CAPITAL MARKETS Begins Coverage of Adagene Inc. - Depositary Receipt (ADAG) with a Buy Rating

Sep 19 2025NASDAQ.COM

Adagene's ADG126 to Be Featured in Two Presentations at the 2025 CSCO Meeting in Jinan, China

Sep 05 2025Newsfilter

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Aug 06 2025Benzinga

Adagene Announces Upto $25 Mln Investment From Sanofi, Stock Up In Pre-Market

Jul 01 2025NASDAQ.COM

Adagene to Present at Jefferies Global Healthcare Conference 2025

May 27 2025Newsfilter

Adani Group to invest additional $10 billion in Indian data centers - Bloomberg By Investing.com

Apr 21 2025Investing.com

Adagene to Present at Stifel's 2025 Virtual Targeted Oncology Forum

Apr 07 2025Newsfilter

HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $8 Price Target

Apr 03 2025Benzinga

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 24 2025Newsfilter